Pharmaceutical Market Europe • July / August 2020 • 3
CONTENTS
NEWS & COLUMNS
6-7 NEWS
Roche agrees deal for Blueprint’s RET programme; IFPMA launches AMR Action Fund
8-11 CORONAVIRUS NEWS
Moderna’s COVID-19 vaccine shows early promise; Remdesivir cuts risk of death in COVID-19 patients
12 DARWIN'S MEDICINE
Socially distanced strategising - the new normal can improve how you create strategy
13 POLICY AND PUBLIC HEALTH
From testing to reopening to vetting scientific articles, we have lost track of time
14 TRUST
Years to build, seconds to break and forever to repair
15 LAUNCH LEADERS' BLOG
What does the launch environment look like in the 'next normal'?
FEATURES
16-17 GUT INSTINCTS LEAD TAKEDA TO PIPELINE SUCCESS
Takeda's Asit Parikh talks about a game changer for IBD patients and the company’s long-term strategy for gene and cell therapy
18-19 AI AND LIFE SCIENCES
Looking at the key areas where AI is being applied : drug discovery, clinical decision-making and clinical trials
20-21 HAS AI BEEN THE KEY TO TACKLING THE CORONAVIRUS PANDEMIC?
How the healthcare sector has become increasingly reliant on the help of technology to offer timely solutionss for COVID-19
COMMUNIQUE
MARKETING & COMMS
22-25 COMMUNIQUÉ AWARDS 2020
All the winners from the first virtual Communiqué Awards ceremony
26-27 THE SCIENCE OF BEHAVIOUR
Why the application of behavioural science will be key to better healthy
38-39 WE NEED TO KEEP LEARNING TO KEEP INNOVATING
How embracing experimentation and making space for learning can fuel creativity
40-41 EXPLOITING THE VALUE OF DATA IN PHARMA
How using data in an agile way can accelerate innovation and clinical trials
45 HEALTHCARE COMMS
Sibel Health wins inaugural Spinoff Prize; The Creative Engagement Group acquires Cormis
46 PEOPLE
Q&A with Anna Korving
CAREERS & RECRUITMENT
42-44 APPOINTMENTS
Changes at the EMA, Gilead and BeiGene
47 PHARMA MARKETING JOBS
Jobs in pharma marketing, sales and communications